In the past one month, GSK Pharma has outperformed the market by surging 22 per cent, after the company reported a strong set of numbers for the quarter ended September 2021 (Q2FY22). In comparison, the S&P BSE Sensex was down 4 per cent.
First Published: Nov 25 2021 | 12:20 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com